Herbal mixture plus chemo before surgery for advanced stomach cancer
Part of Cancer, Digestive system clinical trials.
This trial tests whether adding an herbal mixture (Shenqi Fuwei Mixture) to standard chemotherapy before surgery can help treat locally advanced stomach cancer. It is for people whose cancer has not spread to distant sites and who are healthy enough to undergo treatment and surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of stomach cancer called adenocarcinoma.
- Your cancer is advanced but can still be removed with surgery (stage cT3-4aN+ or cT4b).
- You have not had any previous cancer treatments like chemotherapy, radiation, or immunotherapy.
- You are between 18 and 75 years old and are in generally good health (able to do most daily activities).
- Your cancer has not spread to other organs (no distant metastases).
- You are not pregnant and do not have serious heart or mental health conditions.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three drugs (envollizumab, fruquintinib, and chemotherapy) given before surgery, to see if it can shrink stomach cancer enough to make it removable. It compares this combination to chemotherapy alone.
This trial tests whether giving a combination of chemotherapy and an immunotherapy drug before surgery helps shrink stomach cancer tumors and improve outcomes. The treatment is given in the neoadjuvant (before surgery) setting for stomach cancer that is locally advanced but not spread.
This trial tests a new drug combined with chemotherapy before surgery for stomach cancer that has spread to nearby areas. It aims to shrink the tumor to make surgery more successful.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This study tests a combination of four drugs that are given before surgery for stomach cancer. The goal is to shrink the tumor and make it easier to remove, with the hope of improving long-term outcomes.
This trial tests giving a combination of immunotherapy, a growth factor to boost white blood cells, and chemotherapy before surgery for stomach cancer. The goal is to shrink the tumor and improve surgical outcomes.
Hear when a new Gastric Cancer, Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.